Search by Drug Name or NDC

    NDC 67877-0443-38 Rabeprazole Sodium 20 mg/1 Details

    Rabeprazole Sodium 20 mg/1

    Rabeprazole Sodium is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is RABEPRAZOLE SODIUM.

    Product Information

    NDC 67877-0443
    Product ID 67877-443_f3b11232-76f6-4cfd-84ac-73df3fa0d3a4
    Associated GPIs 49270076100620
    GCN Sequence Number 040941
    GCN Sequence Number Description rabeprazole sodium TABLET DR 20 MG ORAL
    HIC3 D4J
    HIC3 Description PROTON-PUMP INHIBITORS
    GCN 94639
    HICL Sequence Number 018847
    HICL Sequence Number Description RABEPRAZOLE SODIUM
    Brand/Generic Generic
    Proprietary Name Rabeprazole Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Rabeprazole Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name RABEPRAZOLE SODIUM
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208644
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0443-38 (67877044338)

    NDC Package Code 67877-443-38
    Billing NDC 67877044338
    Package 100 POUCH in 1 CARTON (67877-443-38) / 1 BLISTER PACK in 1 POUCH / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (67877-443-33)
    Marketing Start Date 2018-04-27
    NDC Exclude Flag N
    Pricing Information N/A